Two National Health Service workers with long histories of severe allergies received the Pfizer, BioNTech coronavirus vaccine Tuesday. Both are now recovering after bad reactions to the dose.
COVID-19’s spread in Georgia continues at a relentless pace.
The number of virus cases here has surged past the 500,000 mark, including 58,000 positives from rapid antigen tests. There have been more than 9,000 confirmed COVID deaths in Georgia over the course of the pandemic.
And Georgia reported 5,500 new COVID infections Monday, including antigen test results.
The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.
Today on Political Rewind: Sen. Kelly Loeffler and Democratic challenger the Rev. Raphael Warnock traded attacks in the runoff debates. Loeffler dodged questions about President Donald Trump’s false election claims while Warnock worked to fend off accusations that his liberal policies are out of step with Georgia values.
The U.K. was the first Western country to approve Pfizer's coronavirus vaccine for emergency use. In the U.S., the Food and Drug Administration could vote to approve the vaccine as early as Thursday.
Pence visited the Centers For Disease Control and Prevention to highlight promising vaccine developments, but he received a grim assessment of the current state of the pandemic in the U.S.
Some Americans say they don't want to be vaccinated against the coronavirus. NPR's Ari Shapiro talks with the Ad Council's CEO about public health messaging and ways to reach vaccine skeptics.
State leaders implemented sweeping measures to slow the spread of the coronavirus. Here's how changes in case numbers are affecting their reopening plans.
By refusing to pass COVID-19 relief, Sens. David Perdue and Kelly Loeffler are turning their backs on every Georgian, including every health care worker in Georgia, local doctors with the Committee to Protect Medicare say.
A new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses SARS-CoV-2 transmission in some animals within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.
Those getting jobless benefits had fewer symptoms of depression and lower anxiety, according to a new study. But losing that aid could result in deaths that are not directly from the coronavirus.
